The background of β-oxidation disorders in humans. II. Laboratoy studies and clinical data

Central European Journal of Public Health

Volumn 12, Issue 2, 2004, Pages 91-93

  Kuryl, T ^a   Debski, B ^a   Lipko, M ^a   Martinik, K ^b  

^a WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

^b UNIVERSITY OF HRADEC KRALOVE   (Czech Republic)

Author keywords

oxidation; Broilers; Chromium ions; Energy production; Human; Laboratory method; Rats

Indexed keywords

CARNITINE; CHROMIUM; FRUCTAN; INULIN;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CITRIC ACID CYCLE; CLINICAL MEDICINE; DIET; ENERGY YIELD; ENZYME REGULATION; FATTY ACID OXIDATION; GLYCOLYSIS; HORMONAL REGULATION; HUMAN; LABORATORY; LIPID METABOLISM; LIPOLYSIS; NONHUMAN; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; CHOLESTEROL; CHROMIUM; CLINICAL TRIALS; DIET; FATTY ACIDS; GLYCOLYSIS; HUMANS; INULIN; MITOCHONDRIAL DISEASES; OLIGOSACCHARIDES; OXIDATION-REDUCTION; TRIGLYCERIDES;

EID: 3042540509     PISSN: 12107778     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Quintana PL, Crespo SP: Diagnostic approach and treatment of inherited mitochondrial fatty acid oxidation disorders. An Esp Pediatr 2001; 55(6): 524-534.
2. Eaton S, Barlett K, Pourfarzam M: Mammalian mitochondrial β-oxidation. Biochem J 1996; 320: 345-347.
3. Murphy MSR, Kammana VS, Pande SV: A carnitine/acylcarnitine translocase assay applicable to biopsied specimens without requirement mitochondrial isolation. Biochem J 1986; 236: 143-148.
4. Pande SV, Brivet M, Slama A, Demangre F, Autrant CH, Sandubray J-M: Carnitine-acylcarnitine translocase deficiency with severe hypoglycemia and auriculo ventricular block. J Clin Invest 1993; 91: 1247-1252.
5. Rasmussen UF, Krustrup P, Bangsbo J, Rasmussen HN: The effect of high-intensity exhaustive exercise studies in isolated mitochondria from human skeletal muscle. Pflugers Arch 2001; 443(2): 180-187.
6. -3H] myristic acid by lymphocyte. Screening test of inherited disorders of activation, transport and mitochondrial oxidation of fatty acids. Atherosclerosa 2001; 23: 23-26.
7. -3H] myristic acid from the detection of defects of fatty acids oxidation in intact cultured fibroblasts. J Inher Metab Dis 1990; 13: 58-68.
8. Horowitz JF: Regulation of lipid mobilization and oxidation during exercise in obesity. Exerc Sport Sci Rev 2001; 29(1): 42-46.
9. Lipko M, Kuryl T, Dȩbski B: Mechanism of insulin-like effect of chromium ions on glucose uptake by C2Cl2 mouse myotubes. University of Hradec Králové, Pedagogical Faculty, 2002; IX, pp. 348-349.
10. Lipko M, Orzechowski A, Kuryl T, Dȩbski B: Influence of chromium on glucose uptake in mouse myotubes. Mengen- und Spurenelemente, 21 Arbeistagung 2002, Friedrich Schiller-Universität, Jena, Schubert Verlag, Leipzig, 2002; pp. 560-566.
11. Anderson RA: Elevated intake of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes 1997; 46: 1786-1791.
12. Anderson RA: Chromium in the prevention and control of diabetes. Diabetes Metab 2000; 26 (1): 22-27.
13. -3H] oleate for detection and diagnosis of medium and long-chain fatty acid oxidation disorders in intact cultured fibroblasts. Adv Exp Med Biol 1999; 466: 321-325.
14. Wanders RJA, Vraken MEJ, Den Boer FA: Disorders of mitochondrial fatty acyl-CoA β-oxidation. J Inher Metab Dis 1999; 22: 442-487.
15. Treem WR, Stanley CA, Finegold DN, Hale DE, Coates PA: Primary camitine deficiency due to a failure of carnitine transport in kidney, muscle and fibroblasts. N Engl J Med 1988; 319: 1331-1336.
16. Giros M, Ruiz M, Ribes A, Pampols T: The diagnosis of perxisomal disorders in Spain during the period 1987-1997. Rev Neurol 1999; Suppl. 1:40-44.
17. Wanders RJ, Vraken P, Ferdinandusse S, Jansen GA, Waterham HR, van Roermund CW, van Grunsven EG: Peroxisomal fatty acid α-and-β- oxidation in humans:enzymology, peroxisomal metabolite transporters and peroxisomal disease. Biochem Soc Trans 2001; 29(2): 250-267.
18. Kuryl T, Lipko M, Dȩbski B: Metabolism of fatty acids in broiler chicken is affected by chromium. In: Khassanova L, Collery P, Maymard I, Khassanova Z, Etienne JC (eds), Metal ions in biology and medicine, John Libbey Eurotext, 2002: vol. 7, pp. 454-459.
19. Pettegrew JW, Levine J, McClure RJ: Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer's disease and geriatric depression. Mol. Psychiat 2000; 5(6): 616-632.
20. Winter S, Birek L, Walker T, Phalin-Roque J, Chandler MJ, Field C, Zorn E: Therapy of metabolic disorders with intravenous (i.v.) access ports and long term intravenous L-carnitine therapy. Southeast Asian J Trop Med Publ Health 1999; 30:(Suppl: 2) 152-153.
21. Debski B, Krynski A, Zalewski W, Kuryl T: Chromium-yeast influence on broilers in industrial farming system. Proc Int Soc Animal Hyg 2003; 2: 663-666.
22. Letexier D, Diraison F, Beylot M: Addition of inulin to a moderately high-carbohydrate diet reduces hepatic lipogenesis and plasma triacylglycerol concentrations in human. Am J Clin Nutr 2003; 77(3): 559-564.
23. Brighenti F, Casiraghi MC, Canzi E, Ferrari A: Effect of consumption of a ready-to-eat breakfast cereal containing inulin on the intestinal milieu and blood lipids in healthy male volunteers. Eur Clin Nutr 1999; 53(9): 726-733.
24. Roberfroid MB, Cumps J, Devogelaer JP: Dietary chicory inulin increases whole-body bone mineral density in growing male rats. J Nutr 2002; 132(12): 3599-3602.
25. Ellegard L, Andersson H, Bosaeus I: Inulin and oligofructose do not influence the absorption of cholesterol, or the excretion of cholesterol, Ca, Mg, Zn, Fe, bile acids but increases energy excretion in the ileostomy subjects. Eur J Clin Nutr 1997; 5(1): 1-5.
26. Kuryl T, Krejpcio Z, Wojciak R, Lipko M, Debski B: The influence of chromium and fructans enriched diet on β-oxidation activity of fatty acids in rat lymphocytes, Mengen- und Spurenelemente, Friedrich Schiller- Universität Jena 2003 (in press).